Home/Filings/4/0001209191-18-061395
4//SEC Filing

Jutt-Eghbali Salma 4

Accession 0001209191-18-061395

CIK 0001069308other

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 6:20 PM ET

Size

5.8 KB

Accession

0001209191-18-061395

Insider Transaction Report

Form 4
Period: 2018-12-04
Jutt-Eghbali Salma
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-12-04+60,00060,000 total
    Exercise: $22.18Exp: 2028-12-04Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable over four years as follows: 25% of the shares vest on December 4, 2019, and the remaining 75% vesting quarterly over the remaining three years.

Issuer

Acer Therapeutics Inc.

CIK 0001069308

Entity typeother

Related Parties

1
  • filerCIK 0001760856

Filing Metadata

Form type
4
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 6:20 PM ET
Size
5.8 KB